Hjem › Lungesygdomme › New Jersey
Lungesygdomme kliniske forsøg i New Jersey
6 studier for Lungesygdomme søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Holy Name Medical Center, Teaneck
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07013474A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Rutgers, Robert Wood Johnson Medical School, New Brunswick
- Circuit Clinical / Impact Medical Allergy, Asthma & Immunology, Riverdale
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. sep. 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The Valley Hospital, Inc., Paramus
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Cancer Center - Monmouth, Middletown
- Memorial Sloan Kettering Cancer Center - Bergen, Montvale
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT05967689Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- MD Anderson Cooper, Camden
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 26. jun. 2026 · NCT04614103TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
- Rutgers Cancer Institute, New Brunswick
RekruttererFrivillige med god helbredstilstand velkomne
Alder 50 til 77 · Alle køn · Opdateret 2. dec. 2025 · NCT07165691Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.